Financhill
Back

Viatris Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
33

VTRS
Viatris

Last Price:
$9.2300
Seasonality Move:
4.69%
Buy
54

SRPT
Sarepta Therapeutics

Last Price:
$99.80
Seasonality Move:
6.73%
Sell
33
Viatris (VTRS) is a Sell

Is Viatris a Buy, Sell or Hold?

  • The current Viatris [VTRS] share price is $9.3300. The Score for VTRS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • VTRS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $100.71. The Score for SRPT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

VTRS Stock Price Chart

What is Viatris's stock price today?

  • The Viatris share price today is $9.3300
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VTRS is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $100.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

VTRS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.5 Sell
Relative Strength Index (14 RSI): 29.11 Sell
Chaikin Money Flow: -3939696 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.7232 - 11.2032) Sell
Bollinger Bands (100): (10.7369 - 12.7969) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.22 Sell
Relative Strength Index (14 RSI): 38.38 Sell
Chaikin Money Flow: 544784 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.87 - 112.63) Sell
Bollinger Bands (100): (110.05 - 127.23) Sell

VTRS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.43 Sell
20-day SMA: 10.35 Sell
50-day SMA: 11.1 Sell
200-day SMA: 11.5 Sell
8-day EMA: 9.68 Sell
20-day EMA: 10.2 Sell
50-day EMA: 10.91 Sell
200-day EMA: 11.45 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.91 Sell
20-day SMA: 106.68 Sell
50-day SMA: 114.29 Sell
200-day SMA: 126.68 Sell
8-day EMA: 104.06 Sell
20-day EMA: 106.89 Sell
50-day EMA: 112.29 Sell
200-day EMA: 121 Sell

Viatris Earnings Growth & VTRS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.48 per share, and an increase next year of $0.20 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

Viatris Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):